Huons Group Chairman Yoon Sung-tae (right) and Vasu Group CEO Abhinay Bezgam (left) are holding the completion ceremony for the local assembly production line. Provided by Huons Meditech
Huons Meditech, the medical device specialist of Huons Group, announced on the 24th that it held a completion ceremony on the 23rd (local time) for an endoscope washer-disinfector local assembly (Complete Knock Down, CKD) production line in Hyderabad, Telangana State, India, in partnership with India’s Vasu Group.
The ceremony was attended by Huons Group Chairman Yoon Sung-tae, executives and employees of Huons Meditech, and executives and employees of Vasu Group. Vasu Group is an Indian pharmaceutical and medical device distribution company established in 1985. It owns a manufacturing plant in Hyderabad, Telangana State, the hub of India’s medical device industry. In March last year, Huons Meditech signed an agreement with Vasu Group on entry into the Indian market and has since promoted CKD production by exporting parts for assembly in India. Endoscope washer-disinfectors produced under the CKD scheme receive domestic production benefits in India and are supplied throughout the country. Huons Meditech plans to enhance local price competitiveness and brand awareness in India.
To ensure stable CKD production, Vasu Group engineers visited Korea last month and received training at Huons Meditech’s headquarters on CKD production and quality control. The training was conducted with the aim of technology transfer for CKD production and establishment of quality standards. On the 20th, Huons Meditech executives and employees visited Vasu Group’s production line in Hyderabad, India, to inspect the endoscope washer-disinfector CKD production line and provide additional training.
Through this local production cooperation with Vasu Group, Huons Meditech plans to focus on securing price competitiveness, improving logistics efficiency, and accelerating overseas market expansion. The company also plans to accelerate its penetration of the Indian market by expanding CKD items centered on key product groups such as extracorporeal shock wave lithotripters and disinfectants.
Ha Chang-woo, CEO of Huons Meditech, stated, “This completion ceremony will serve as an important starting point for both companies to pursue mutual growth through strategic collaboration.” He added, “The completion of this CKD production line will be the cornerstone of our localization strategy and a key pillar of Huons Meditech’s global expansion strategy this year.”
Lee Han-gyu
AI-translated with ChatGPT. Provided as is; original Korean text prevails.
ⓒ dongA.com. All rights reserved. Reproduction, redistribution, or use for AI training prohibited.
